Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Chem Biol Drug Des. 2021 Jan 26;97(5):1059–1078. doi: 10.1111/cbdd.13826

FIGURE 3.

FIGURE 3

Isothiocyanate-ARi hybrid drugs reduce viability of PCa cells. (a) VCaP cells were treated with indicated compounds at various concentrations for 72 hr. Data were plotted as means ± SEM (n = 6–8). (b) 22Rv1, C4–2, and VCaP cells were treated with indicated compounds at 5 μM for 72 hr. Data represent mean ± SD (n = 6–8). Cell viability was measured using MTT assay. *p < .05; ****p < .0001. P-NAC, NAC conjugate of PEITC